PURE PARACETAMOL FOR DIRECT COMPRESSION .2. STUDY OF THE PHYSICOCHEMICAL AND MECHANICAL-PROPERTIES OF SINTERED-LIKE CRYSTALS OF PARACETAMOL

被引:18
作者
FACHAUX, JM
GUYOTHERMANN, AM
GUYOT, JC
CONFLANT, P
DRACHE, M
VEESLER, S
BOISTELLE, R
机构
[1] UNIV SCI & TECH LILLE,CRISTALLOCHIM & PHYSICOCHIM SOLIDE LAB,CNRS,URA 452,F-59652 VILLENEUVE DASCQ,FRANCE
[2] CNRS,CRMC2,CTR RECH MECANISMES CROISSANCE CRISTALLINE,F-13288 MARSEILLE,FRANCE
关键词
PARACETAMOL; COMPRESSION; DISSOLUTION; CRYSTAL STRUCTURE;
D O I
10.1016/0032-5910(94)02920-J
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Part I described the production of sintered-like Paracetamol crystals. In this second part, the physicochemical and technological behaviour of these crystals is investigated. The wettability and dissolution properties are then studied. The crystals exhibit a polyhedric habit which induces good flow properties. The porous crystal structure, resulting from the arrangement of the microcrystallites inside the crystalline particle, greatly improves compression ability, probably because of increased plasticity. Moreover, their porous crystal structure induces fast dissolution. Tablets were prepared by direct compression from a mixture of FGH Paracetamol with the usual excipients. These tablets disintegrate instantaneously and Paracetamol dissolution is complete within 10 min.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 7 条
[1]   ELABORATION AND PHYSICAL STUDY OF AN OXODIPINE SOLID DISPERSION IN ORDER TO FORMULATE TABLETS [J].
GUILLAUME, F ;
GUYOTHERMANN, AM ;
DUCLOS, R ;
BESANCON, P ;
ORECCHIONI, AM ;
DRACHE, M ;
CONFLANT, P ;
GADEFAIT, A ;
BECOURT, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (08) :811-827
[2]   MONOCLINIC FORM OF PARA-HYDROXYACETANILIDE [J].
HAISA, M ;
KASHINO, S ;
KAWAI, R ;
MAEDA, H .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1976, 32 (APR15) :1283-1285
[3]  
ICHIKAWA J, 1988, CHEM PHARM BULL, V36, P2699, DOI 10.1248/cpb.36.2699
[4]   AN ATTEMPT AT BRINGING TO LIGHT A PHASE INVERSION IN A BINARY MIXTURE OF TWO-DIMENSIONAL ROUNDED PARTICLES [J].
LEFEBVRE, C ;
BARTHELEMY, C ;
GUYOTHERMANN, AM ;
GUYOT, JC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (15-17) :2443-2465
[5]  
MERLE C, 1977, B SOC PHARM LILLE, P87
[6]  
RABIANT J, 1991, STP PHARM PRATIQUES, V1, P278
[7]  
1994, FRENCH PHARMACOPOEIA, P555